✦ LIBER ✦

A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy

✍ Scribed by Michael Fiegl; Thomas Büchner; Wolfgang Hiddemann; Jan Braess

Publisher: Springer
Year: 2004
Tongue: English
Weight: 84 KB
Volume: 84
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-004-0943-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive chemotherapy with idarubicin,

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

✍ W. K. Hofmann; G. Heil; C. Zander; S. Wiebe; O. G. Ottmann; L. Bergmann; K. Hoef 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 109 KB

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the southeastern cancer study group

✍ Hillard M. Lazarus; W. Ralph Vogler; C. Patrick Burns; Elliott F. Winton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Phase 1 study of arsenic trioxide, high-

Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia

✍ Meir Wetzler; Chris Andrews; Laurie A. Ford; Sheila Tighe; Maurice Barcos; Sheil 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 2 views